Page 3 - Best Non-Hodgkin's lymphoma doctors: TOP 74 doctors

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Ofer Spielberg is an oncologist specializing in Non-Hodgkin's lymphoma at Assuta Medical Center.

• Focuses on advanced diagnostic methods and tailored treatment protocols
• Integrates latest clinical research into surgical practice
• Available to advise on both routine and complex lymphoma cases

Recognized by Forbes as one of the best doctors in 2018 – Dr. Stepensky has performed over 3,500 bone marrow transplants at Hadassah Medical Center.

• 28 years of experience of experience in pediatric hematology
• Specializes in treating children with rare blood cancers
• Known among patients as 'the one who transplants life'
• Works at Hadassah Medical Center – a leading Israeli hospital

Professor Zila Zuckerman specializes in hematology and transplantology at Rambam Medical Center.

• Expertise in Non-Hodgkin's lymphoma treatment
• Specializes in hematology and transplantology
• Works at Rambam Medical Center

Specializes exclusively in hematology with a focus on treating lymphomas. He practices at Rambam Medical Center – a leading Israeli hospital.

• Offers a dedicated focus on the complex care lymphoma requires
• Possesses in-depth knowledge of lymphoma-specific treatments and protocols
• His hematology specialization ensures up-to-date care for blood cancers

Professor Bosch is a world-renowned leader in Chronic Lymphocytic Leukemia (CLL) and lymphoproliferative disorders, pioneering new treatments and technologies.

• Head of Hematology at IOB Institute of Oncology since 2004
• Published over 100 articles in top journals like The New England Journal of Medicine
• Currently involved in more than 80 clinical trials from phase 1 to 3
• President of the Spanish group for the study of CLL (GELLC)

Prof. Dr. Serdar Bedii Omay has published 65+ scientific articles on hematology and bone marrow transplantation. He trained at Japan's Mie Medical Faculty.

• Specialized in hematology with over 36 years of experience of experience
• Professor at Ege University and Karadeniz Technical University
• Expert in molecular hematology
• Worked at prestigious institutions including Hacettepe Faculty of Medicine

Associate Professor Rafet Eren specializes in hematology with nearly 50 publications in national and international journals.

• Member of the European Society of Hematology and Turkish Hematology Association
• Recipient of the Young Researcher Award at the 42nd National Hematology Congress
• Fluent in English
• Works at Biruni University Hospital

Over 26 years of experience specializing in pediatric hematology-oncology, Dr. Apak has treated numerous complex lymphoma cases at Biruni University Hospital.

• Leads the Pediatric Hematology-Oncology Division at Cerrahpaşa
• Specializes in CAR T-cell therapy and advanced leukemia treatments
• Authored 75 international publications on pediatric cancer
• Assistant editor for the Turkish Pediatrics Archives Periodical

Prof. Baytan specializes in childhood cancers, including Non-Hodgkin's lymphoma, with over 34 years of experience of experience in pediatric hematology and oncology.

• Published 15 articles in international refereed journals
• Specialized in leukemia and lymphoma treatments
• Authored 3 books or book chapters in local and foreign languages
• Assistant Professor in Pediatric Hematology at Uludağ University

Specializes in Non-Hodgkin's lymphoma at Liv Hospital Ulus – with extensive experience in hematology and oncology.

• Board-certified hematologist with over 36 years of experience of experience
• Published 32 articles in international peer-reviewed journals
• Member of the Turkish Society of Hematology
• Former lecturer at Istanbul Training and Research Hospital